Correlation Between NewAmsterdam Pharma and Zealand Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NewAmsterdam Pharma and Zealand Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NewAmsterdam Pharma and Zealand Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NewAmsterdam Pharma and Zealand Pharma AS, you can compare the effects of market volatilities on NewAmsterdam Pharma and Zealand Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NewAmsterdam Pharma with a short position of Zealand Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of NewAmsterdam Pharma and Zealand Pharma.

Diversification Opportunities for NewAmsterdam Pharma and Zealand Pharma

-0.68
  Correlation Coefficient

Excellent diversification

The 3 months correlation between NewAmsterdam and Zealand is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding NewAmsterdam Pharma and Zealand Pharma AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zealand Pharma AS and NewAmsterdam Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NewAmsterdam Pharma are associated (or correlated) with Zealand Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zealand Pharma AS has no effect on the direction of NewAmsterdam Pharma i.e., NewAmsterdam Pharma and Zealand Pharma go up and down completely randomly.

Pair Corralation between NewAmsterdam Pharma and Zealand Pharma

Given the investment horizon of 90 days NewAmsterdam Pharma is expected to generate 1.19 times more return on investment than Zealand Pharma. However, NewAmsterdam Pharma is 1.19 times more volatile than Zealand Pharma AS. It trades about 0.11 of its potential returns per unit of risk. Zealand Pharma AS is currently generating about -0.08 per unit of risk. If you would invest  1,591  in NewAmsterdam Pharma on September 2, 2024 and sell it today you would earn a total of  394.00  from holding NewAmsterdam Pharma or generate 24.76% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy98.46%
ValuesDaily Returns

NewAmsterdam Pharma  vs.  Zealand Pharma AS

 Performance 
       Timeline  
NewAmsterdam Pharma 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in NewAmsterdam Pharma are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak primary indicators, NewAmsterdam Pharma unveiled solid returns over the last few months and may actually be approaching a breakup point.
Zealand Pharma AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Zealand Pharma AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite abnormal performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

NewAmsterdam Pharma and Zealand Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NewAmsterdam Pharma and Zealand Pharma

The main advantage of trading using opposite NewAmsterdam Pharma and Zealand Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NewAmsterdam Pharma position performs unexpectedly, Zealand Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zealand Pharma will offset losses from the drop in Zealand Pharma's long position.
The idea behind NewAmsterdam Pharma and Zealand Pharma AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities